Clinical Trials in Denver

Showing 7181-7200 of 18,161 trials

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

NCT02795156

With the increased availability of next-generation sequencing, oncologists are starting to incorporate genomic profiling into routine care of cancer patients. If a genomic alteration is identified during profiling, it could help guide the choice of therapy and improve treatment outcomes. This study will examine the anti-tumor activity of selected commercially available molecularly matched targeted therapies in patients who have failed first-line treatment for one of the following tumor types: non-small cell lung cancers; urothelial cancer; non-colon gastrointestinal cancers, and upper aerodigestive tract cancer.

Non-small Cell Lung CarcinomaUrothelial CarcinomaGastrointestinal Carcinoma, Non-colon+1 more

SCRI Development Innovations, LLC100 participantsStarted Sep 2016

Denver, Colorado, United States • Fort Myers, Florida, United States • St. Petersburg, Florida, United States +5 more locations

COMPLETED< 1 mile

Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence

NCT02348112

The aim of this postmarket study is to compare the safety and effectiveness of the Altis Single Incision Sling (SIS) to an FDA cleared transobturator and/or retropubic sling through 36 months.

Stress Urinary Incontinence

Coloplast A/S416 participantsStarted Jan 2015

Stanford, California, United States • Denver, Colorado, United States • Hialeah, Florida, United States +24 more locations

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence

Find Trials by Condition in Denver

A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study

Online Education Module to Accurately Classify Polyp Size

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Sleep, Blood Pressure and Vascular Health

Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma

ALTO-100 in MDD and/or PTSD

Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain

Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease

Trident II Revision Outcomes Study

Pediatric Vasculitis Initiative

Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)

A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer

Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS